AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3

Sitadin M Tablet

Prescription Icon
Prescription Required

Marketer

Astrodin Life Science Pvt Ltd

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Sitadin M Tablet

Glycoduo tablets combine two medications to manage elevated blood glucose in individuals with type 2 diabetes. This helps prevent serious diabetic complications like renal impairment and vision loss, potentially lowering the risk of cardiovascular events. Glycoduo may be used alone or in conjunction with other antidiabetic agents, and its effectiveness is enhanced by a balanced diet and regular physical activity. Dosage is tailored to individual needs, considering current health status, blood sugar readings, and other medications. Taking it with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes benefits; discontinuation should only occur under medical supervision. Adherence to the prescribed diet and exercise plan is crucial for optimal diabetes control, as lifestyle significantly impacts management. Common side effects include diarrhea, nausea, vomiting, indigestion, headache, and pharyngitis. Hypoglycemia is a potential adverse effect, especially when used with insulin or sulfonylureas, requiring knowledge of its recognition and management. This medication isn't universally suitable. Prior to use, disclose any history of kidney, liver, or heart disease, pancreatic issues, or excessive alcohol consumption to your physician. Pregnant or lactating individuals should seek medical counsel before initiating treatment. Interactions with other drugs are possible; inform your doctor of all medications being taken to ensure safety. Alcohol consumption, which can lower blood glucose, should be limited. Your doctor will monitor kidney function and blood sugar levels throughout treatment.

Uses of Sitadin M Tablet

Managing Type 2 Diabetes

Major Benefits of Sitadin M Tablet:

Consume this medication precisely as prescribed by your physician, adhering to the recommended dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Sitadin M Tablet with a meal.

Common Side effects of Sitadin M Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitadin M Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Sitadin M Tablet with a meal.

How Sitadin M Tablet works:

Sitagliptin and metformin, the components of Sitadin M Tablet, work synergistically to manage blood glucose. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and decreases hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and increases insulin sensitivity. This combined action leads to superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol consumption with Sitadin M Tablet is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Sitadin M Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any possible risks prior to prescription. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Sitadin M Tablet while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar abnormalities.

KidneyKidneyCAUTION

Patients with kidney impairment should use Sitadin M Tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates Sitadin M Tablet use. Consult your physician. Regular kidney function monitoring is recommended during treatment.

LiverLiverUNSAFE

Patients with liver disorders should not take Sitadin M Tablets due to potential safety concerns. A physician's consultation is recommended.

What if you forget to take Sitadin M Tablet :

Should you forget a Sitadin M Tablet dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Sitadin M Tablet

LabelValue
Potential for Dependence None.
Type of Treatment Medication for diabetes

FAQs on Sitadin M Tablet

Sitadin M Tablet combines sitagliptin and metformin to manage type 2 diabetes mellitus in adults. This medication enhances blood sugar control when used with a healthy diet and regular physical activity. Metformin reduces liver glucose production and boosts insulin sensitivity. Sitagliptin's action involves DPP4 enzyme inhibition, leading to increased pancreatic insulin secretion. This formulation is unsuitable for individuals under 18.
Prolonged Sitadin M Tablet use can indeed lead to vitamin B12 deficiency. This medication impairs the stomach's absorption of vitamin B12. Consequently, untreated deficiency may result in anemia and neurological issues, manifesting as tingling or numbness in the extremities, weakness, urinary dysfunction, cognitive changes, and gait instability. Preventive measures, as proposed by some studies, include annual supplemental vitamin B12 intake.
Sitadin M Tablet may cause common side effects including low blood sugar (hypoglycemia), taste changes, nausea, abdominal pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis may occur. Prolonged use can result in vitamin B12 deficiency.
Patients with hypersensitivity to any ingredient within Sitadin M Tablet should not use this medication. Similarly, its use is contraindicated in individuals experiencing severe renal or hepatic dysfunction, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitadin M Tablet and alcohol is unsafe due to the heightened risk of lactic acidosis.
Store this medication in its original, tightly sealed container or packaging, following the storage guidelines provided on the label or packaging. Discard any leftover medication and ensure it remains inaccessible to children, pets, and others.
Lactic acidosis, a serious medical condition characterized by excessive blood lactic acid, is a potential consequence of Sitadin M Tablet use. This complication, also termed Metformin-associated lactic acidosis (MALA), is infrequent but warrants caution. Its occurrence is heightened in individuals with pre-existing kidney impairment, the elderly, or those consuming significant alcohol. Manifestations can encompass muscle aches or weakness, vertigo, fatigue, peripheral coldness, respiratory distress, nausea, emesis, abdominal discomfort, and bradycardia. Should these symptoms arise, discontinue Sitagliptin + Metformin immediately and seek medical attention.
Sitagliptin and Metformin, combined as Sitadin M Tablet, treat type 2 diabetes mellitus. This medication helps regulate blood sugar in adults when combined with a healthy diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity. Sitagliptin works by suppressing DPP4, thus boosting insulin secretion from the pancreas. This formulation is unsuitable for individuals under 18.
Sitadin M Tablet may cause common side effects including low blood sugar, taste disturbances, nausea, abdominal pain, diarrhea, headache, and upper respiratory infections. Rare but serious adverse reactions such as lactic acidosis are also possible. Prolonged use might result in vitamin B12 deficiency.
Patients with hypersensitivity to Sitadin M Tablet constituents or inactive ingredients should not use this medication. This medicine is contraindicated in individuals with significantly compromised kidney or liver function, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitadin M Tablet and alcohol is unsafe due to a heightened risk of lactic acidosis.
Lactic acidosis, a serious medical condition characterized by excessive blood lactic acid, is a potential consequence of Sitadin M Tablet use. This complication, also termed Metformin-associated lactic acidosis (MALA), is infrequent but necessitates caution. Consequently, its use is contraindicated in individuals with pre-existing kidney impairment, the elderly, or those who consume significant alcohol. Presenting symptoms can encompass muscle aches or weakness, vertigo, fatigue, cold extremities, respiratory distress, nausea, emesis, abdominal discomfort, and bradycardia. Should these symptoms manifest, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged Sitadin M Tablet use can indeed lead to vitamin B12 deficiency by hindering its gastric absorption. This deficiency, if left unaddressed, may result in anemia and neurological complications, manifesting as tingling or numbness in the extremities, muscle weakness, urinary issues, cognitive changes, and impaired balance. To mitigate these risks, supplemental vitamin B12 is recommended by some experts at least annually.
Store this medication in its original, tightly sealed container or packaging, following the storage guidelines provided on the label or packaging insert. Discard any remaining medication after use. Prevent access by children, pets, and others.
Sitadin M Tablet combines sitagliptin and metformin to manage type 2 diabetes mellitus in adults. This medication helps control blood sugar levels when used with a healthy diet and regular physical activity. Metformin reduces glucose production by the liver and enhances insulin sensitivity. Sitagliptin works by suppressing DPP-4 enzyme activity, thus boosting insulin secretion from the pancreas. This formulation is unsuitable for individuals under 18.
Sitadin M Tablet may cause common side effects including low blood sugar (hypoglycemia), taste changes, nausea, abdominal pain, diarrhea, headache, and upper respiratory infections. Rare but serious adverse reactions such as lactic acidosis are possible. Prolonged use may result in vitamin B12 deficiency.
Patients with hypersensitivity to Sitadin M Tablet constituents or inactive ingredients should not use this medication. Similarly, its use is contraindicated in individuals experiencing severe renal or hepatic dysfunction, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitadin M Tablet with alcohol is unsafe and may heighten the risk of developing lactic acidosis.
Sitadin M Tablet use may result in lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this rare complication is linked to metformin use and contraindicated in individuals with pre-existing kidney disease, the elderly, or those consuming significant alcohol. Symptoms can manifest as muscle aches or weakness, lightheadedness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, or bradycardia. Should these symptoms appear, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged Sitadin M Tablet use can indeed lead to vitamin B12 deficiency by hindering its absorption in the gastrointestinal tract. This deficiency, if left unaddressed, may result in anemia and neurological complications, manifesting as paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive changes, and gait instability. To mitigate these risks, supplemental vitamin B12 is recommended by some experts on an annual basis.
Retain this medication within its original, sealed container or packaging. Follow the storage guidelines printed on the packaging or label. Discard any remaining medication. Ensure it remains inaccessible to children, pets, and others.
Sitadin M Tablet
86
MRP 100
14% off